| Nazwa produktu | Kanagliflozyna |
|---|---|
| Numer CAS | 842133-18-0 |
| Wzór cząsteczkowy | C24H25FO5S |
| Masa cząsteczkowa | 444.52 |
| Wygląd | Biały lub prawie biały krystaliczny proszek |
| Oznaczenie (HPLC) | ≥98% |
| Strata przy suszeniu | ≤0,51 TP3T |
| Popiół po spaleniu | ≤0,11 TP3T |
| Metale ciężkie | ≤10 ppm |
| Temperatura topnienia | 150-155°C (dec.) |
| Współczynnik obrotowy | N/A (racemic mixture) |
Potrzebujesz pomocy? Skontaktuj się z naszym zespołem

Canagliflozin is the market leader in the SGLT2 inhibitor class, and it’s easy to see why: it doesn’t just lower blood sugar, it does it by sending excess glucose out through the urine, bypassing insulin entirely. That makes it a powerful tool for type 2 diabetes management, with the added perk of promoting modest weight loss and blood pressure reduction. For formulators, that’s a compelling story to tell — and a product that practically sells itself.
We supply canagliflozin as a high-purity crystalline powder, rigorously tested to meet pharmacopoeial standards. Every batch ships with a full COA, and we offer flexible packaging from 100g R&D quantities to multi-kilogram production lots. Our lead times are fast — typically 7-10 days after order — and we deliver worldwide, so you can keep your supply chain moving without a hitch.